Clinical Features of Peripheral Neurophaty among Onset Type 2 Diabestes Mellitus: A Michigan Neuropathy Screening Instrument (MNSI) Approach


  • Rian Adi Pamungkas Department of Nursing, Faculty of Health Sciences, Universitas Esa Unggul, Jakarta Indonesia
  • Andi Mayasari Usman Department of Nursing, Faculty of Health Science, Universitas Nasional Jakarta Indonesia
  • Kanittha Chamroonsawasdi Department of Family Health, Faculty of Public Health, Mahidol University Thailand


Type 2 diabetes mellitus, Peripheral neuropathy, Clinical features, Michigan Neuropathy Screening Instrument


Introduction: Neuropathy is one of the complications that can occur in patients with Type 2 Diabetes Mellitus, around 21.3% to 34.5%. Untreated neuropathy can lead to diabetic foot ulcers that can lead to amputation. This can be prevented by conducting early detection using a neuropathy screening instrument.Aim: The study aimed to identify neuropathy symptoms through early examination of patients with type 2 diabetes using the Michigan Neuropathy Screening Instrument (MNSI).  Method: The descriptive study with a survey was approached in this study.  One hundred respondents with type 2 diabetes mellitus were selected using the purposive sampling technique.  Results: The results showed that out of 100 patients had clinical symptoms of sensory neuropathy, such as pain and sensitivity disorders in the soles of the feet.  In addition, autonomic neuropathy is in the form of cramps in the leg muscles.  The level of neuropathy showed that from 100 patients, there were 59 respondents with low risk of neuropathy, 40 respondents with moderate risk, and 1 respondent with severe risk.  Conclusion: Patients with Diabetes, primarily Type 2, have various neuropathy symptoms such as impaired nerve function: numbness, burning, and hypersensitivity, which can lead to diabetic foot ulcers.  Therefore, early detection of neuropathy prevention is essential.


Download data is not yet available.

Akaza, M., Akaza, I., Kanouchi, T., Sasano, T., Sumi, Y., & Yokota, T. (2018). Nerve conduction study of the association between glycemic variability and diabetes neuropathy. Diabetology and Metabolic Syndrome, 10(1), 1–8.

Albers, J. W., & Pop-Busui, R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. (2014). Curr Neurol Neurosci Rep, 14, 473

Andersen, S. T., Witte, D. R., Dalsgaard EM, Andersen H, Nawroth, P., Fleming, T., Jensen, T. M., Finnerup, N. B., Jensen, T. S, Lauritzen, T., Feldman, E. L., Callaghan, B. C., & Charles, M.(2018). Risk Factors for Incident Diabetic Polyneuropathy in a Cohort with Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark. Diabetes Care. 41(5),1068-1075. doi: 10.2337/dc17-2062

Bondor, C. I., Veresiu, I. A., Florea, B., Vinik, E. J., Vinik, A. I., & Gavan, N. A (2016). Epidemiology of Diabetic Foot Ulcers and Amputations in Romania: Results of a Cross-Sectional Quality of Life Questionnaire Based Survey. Journal of Diabetes Research. 2016: e5439521

Carmichael, J., Fadavi, H., Ishibashi, F., Shore, A. C., & Tavakoli, M. Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy. (2021). Front Endocrinol (Lausanne). 2021 May 26;12:671257. doi: 10.3389/fendo.2021.671257.

Azhar, F. H. Achmad, S., & Tursina, A. (2017). Hubungan intensitas nyeri dengan kualitas tidur pada pasien neuropati diabetic di Puskesmas Salam Bandung. Prosiding Pendidikan Dokter. 258-267

Freeman, R., Baron, R., Bouhassira, D., Cabrera, J., & Emir, B. (2014). Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain.155:367–376

Halawa, M. R., Karawagh, A., Zeida, A., Mahmoud, A. E., Sakr, M., & Hegazy, A. (2010). Prevalence of painful diabetic peripheral neuropathy among patients suffering from Diabetes mellitus in Saudi Arabia. Curr Med Res Opin. 2010 Feb;26(2):337-43. doi: 10.1185/03007990903471940.

Hwang, S., van Nooten, F., Wells, T., Ryan, A., Crawford, B., Evans, C., et al. (2018). Neuropathic pain: A patient-centered approach to measuring outcomes. Health Expect. 21:774–86. pmid:29656511

Kim, S. S., Won, J. C., Kwon, H. S., Kim, C. H., Lee, J. H., Park, T. S., et al. (2014). Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: Results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Research and Clinical Practice. 103:522–9

Pamungkas, R. A., Usman, A. M., Chamroonsawasdi, K., Khoirunisa, D., Hamzah, A. N., & Hidayat, R. (2022). Challenges of neuropathy screening for preventing diabetic foot ulcers: Perspective of Public Health Nurses in Indonesia. KnE Life Science: 46–58. DOI 10.18502/kls.v7i2.10287

Purwanti, O. S. (2012). Hubungan faktor resiko neuropati dengan kejadian ulkus kaki pada pasien diabetes mellitus di RSUD Moewardi Surakarta. Jurnal Keperawatan. Prosiding Seminar Ilmiah Nasional Kesehatan, ISSN: 2338-2694. /19.%20OKTI.pdf?sequence=1 (diakses tanggal 12 september 2017)

Ponirakis, G., Elhadd, T., Chinnaiyan, S., Dabbous, Z., Siddiqui, M., Al‐Muhammad, H., & et al. (2019. Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar. J Diabetes Investig 2019;10:1558–64. pmid:30860314

Qureshi, M. S., Iqbal, M., Zahoor, S., Ali, J., Javed, M. U. (2017). Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings. J Endocrinol Invest. 40:425–30

Raskin, J., Yili, L., Pritchett., Wang, F., Deborah, N., Amy, L. A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine With Placebo In The Management Of Diabetic Peripheral Neuropathic Pain. Lily Research Laboratories. American Academy Of Pain Medicine. 2005: 346-356

Pop-Busui, R., & Boulton, A. J. M., Eva, L., Feldman, Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017). Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 40:136–154 | DOI: 10.2337/dc16-2042

Timar, B., Timar, R., Gaiță, L., Oancea, C., Levai, C., & Lungeanu, D. (2016). The Impact of Diabetic Neuropathy on Balance and on the Risk of Falls in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. PLoS ONE.11:e0154654

Tesfaye, S., Chaturvedi, N., Eaton, S. E., Ward, J. D., Manes, … Fuller, J. H; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. (2005). N Engl J Med, 352(4), 341-50. doi: 10.1056/NEJMoa032782

Tavakoli, M., Yavuz, g. D., Tahrani, A. A., Selvarajah, D., Bowling, F. L., & Fadavi, H. (2017). Diabetic Neuropathy: Current Status and Future Prospects. Journal of Diabetes Research, 1–2

Trihono. Riset Kesehatan Dasar (Riskesdas). Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. 2013; 1-268

Walter-Höliner, I., Barbarini, D. S., Lütschg, J., Blassnig-Ezeh, A., Zanier, U., Saely, C. H., et al. High Prevalence and Incidence of Diabetic Peripheral Neuropathy in Children and Adolescents with Type 1 Diabetes Mellitus: Results From a Five-Year Prospective Cohort Study (2018). Pediatric Neurology, 80, 51–60.

Zychowska, M., Rojewska, E., Pizewiocka, B., & Mika, J. Mechanisms and pharmacology of diabetic neuropathy-experimental and clinical studies. Institute of Pharmacology. Department of pain pharmacology. (2013). Polish academy of sciences. Poland, 1–10.



How to Cite

Pamungkas, R. A., Usman, A. M. ., & Chamroonsawasdi, K. (2023). Clinical Features of Peripheral Neurophaty among Onset Type 2 Diabestes Mellitus: A Michigan Neuropathy Screening Instrument (MNSI) Approach. Indonesian Contemporary Nursing Journal (ICON Journal), 7(2), 46-52.